Where to listen

April 9, 2024


Antimicrobials are the cornerstone of modern medicine, and this is especially true for patients with cystic fibrosis. People with CF rely on antibiotics for recurring and persistent infections, and with regular use, antibiotics become less and less effective in fighting these infections. Pseudomonas aeroginosa, the most common culprit in CF infections, is especially notorious for its ability to adapt to and evade antibiotics. Hear from a patient advocate, clinician, and policy leader to better understand the unique challenges that superbugs pose for people battling cystic fibrosis.



  • Ella Balasa: Patient Advocate and Engagement Consultant
  • Helen Boucher, MD: Dean and Chief Academic Officer, Tufts University School of Medicine
  • Mary Booth Dwight: Senior Vice President and Chief of Policy and Advocacy, Cystic Fibrosis Foundation



Loading player ...

This podcast is co-created by CIDRAP-ASP and the Antimicrobial Resistance Fighter Coalition (ARFC).

Theme music

  • Artist: Derek Sandbeck
  • Song Title: Power Plugs & Superbugs

Our underwriters